Best deals to access real time data! |
|
SMALL CAP PRO
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
ULTIMATE TRADER
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 34.17 ▲ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Pfizer, Inc. | PFE | NYSE | Ordinary Share | US7170811035 |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0.11 | +0.32% | 34.17 | 34.22 | 33.97 | 34.08 | 34.06 | 16:31:05 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 66,974 | 29,277,622 | $ 34.1123 | $ 998.73M | 18.17M | 29.83 - 37.39 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:35:31 | formt | 74,512 | $34.17 | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Pfizer, Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 203.92B | 5.97B | $ 7.22B | 1.18 | 27.80 | 5.95B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 45.71M | $ 1.28 | 3.75% | -95.8k | 74.40% |
Pfizer, Inc. News
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) • Fri Jun 23, 2017 3:24 PM (1 hour ago)
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) • Fri Jun 23, 2017 3:23 PM (1 hour ago)
Annual Report of Employee Stock Plans (11-k) Edgar (US Regulatory) • Fri Jun 23, 2017 3:21 PM (2 hours ago)
Pfizer Declares 32-Cent Third-Quarter 2017 Dividend Business Wire • Thu Jun 22, 2017 4:05 PM (1 day ago)
S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017 PR Newswire (US) • Wed Jun 21, 2017 10:00 AM (2 days ago)
Pfizer Invites Public To View And Listen To Webcast Of August 1 Conference Call With Analysts Business Wire • Tue Jun 20, 2017 10:00 AM (3 days ago)
For AstraZeneca, Cancer Drug Weighs on Go-It-Alone Stand -- WSJ Dow Jones News • Tue Jun 20, 2017 3:02 AM (4 days ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 32.98 | 34.48 | 32.81 | 0.0000 | 20M | 29M | 24M | 1.19 | 3.61% |
| 1 Month | 32.18 | 34.48 | 31.67 | 0.0000 | 10M | 33M | 21M | 1.99 | 6.18% |
| 3 Months | 34.21 | 34.52 | 31.67 | 0.0000 | 10M | 40M | 21M | -0.04 | -0.12% |
| 6 Months | 32.41 | 34.75 | 30.9 | 0.0000 | 6M | 42M | 22M | 1.76 | 5.43% |
| 1 Year | 33.8 | 37.39 | 29.83 | 0.0000 | 6M | 113M | 21M | 0.37 | 1.09% |
| 3 Years | 29.67 | 37.39 | 27.51 | 0.0000 | 1k | 280M | 25M | 4.5 | 15.17% |
| 5 Years | 22.83 | 37.39 | 22.15 | 0.0000 | 1k | 280M | 28M | 11.34 | 49.67% |
Pfizer, Inc. Description
| Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments—Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare. |
